USPTO serial 76329413
CELLTECH PHARMACEUTICALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCMORROW, RONALD G
- Law office
- TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CELLTECH PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lawrence E. Abelman
LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB666 3RD AVENEW YORK, NY 10017-5621UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and gene therapy products, namely, allergy medications, analgesics, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, anticoagulants, antidepressants, antihistamines, bronchodilators, cardiovascular pharmaceuticals, clinical medical reagents, decongestant tablets, expectorants, hemoglobin, hormones, hydrocortisone, medicated lozenges, migraine treatment preparations muscle relaxants, nasal spray preparations, nausea treatment preparations, pain relief medication, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparation for use in chemotherapy, vaccines; ant-convulsants; gastrointestinal medications; pharmaceutical preparations for the treatment of bone disorders, central nervous system disorders or shock; cough treatment preparations | ACTIVE | — |
| 010 | Inhalers for therapeutic use, sold filled with a pharmaceutical preparation | ACTIVE | — |
| 042 | Research in the fields of biological, medical and chemical sciences and consultation related thereto, product research and development in the fields of biological, medical and chemical sciences | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Celltech Pharmaceuticals Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named CELLTECH PHARMACEUTICALS
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2008 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 14, 2008 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 14, 2007 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Dec 13, 2007 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 6, 2007 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 6, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jun 4, 2007 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 30, 2006 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 8, 2006 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 10, 2006 | PAPER RECEIVED | — | |
| May 25, 2006 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 8, 2006 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 7, 2006 | PAPER RECEIVED | — | |
| Nov 22, 2005 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 16, 2005 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 1, 2004 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jul 21, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 21, 2003 | CFIT | CASE FILE IN TICRS | — |
| Jan 17, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Nov 20, 2002 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Nov 20, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 20, 2002 | PAPER RECEIVED | — | |
| Aug 21, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jul 12, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 12, 2002 | PAPER RECEIVED | — | |
| Jan 11, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 7, 2002 | DOCK | ASSIGNED TO EXAMINER | — |